Related Experiment Video
Updated: Apr 15, 2026
09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
7.2K
Pharmacological Selectivity Within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory
Gavin Rumbaugh1, Stephanie E Daws2, Emin D Ozkan1
1Department of Neuroscience, The Scripps Research Institute, Jupiter, FL, USA.
Summary
Selective inhibition of histone deacetylases (HDACs) impacts memory. Class I HDAC inhibitors like RGFP963, targeting HDAC-1, -2, and -3, enhanced synaptogenesis and rescued memory in an Alzheimer
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Histone deacetylases (HDACs) are implicated in neurological disorders affecting cognition.
- Understanding HDAC isoform-specific roles in memory is crucial for developing targeted therapies.
- Developing selective HDAC inhibitors with procognitive effects and reduced side effects is a key goal.
Purpose of the Study:
- To investigate the biological effects of class I HDAC inhibitors with varying selectivity on cognitive function.
- To assess the impact of these inhibitors on transcriptional activity, synaptic function, and memory in mouse models.
Main Methods:
- Utilized class I HDAC inhibitors with differential selectivity (e.g., RGFP963, RGFP968, RGFP966).
- Assessed synaptogenesis, hippocampal spine density, and memory in mouse models.
- Performed genome-wide gene expression analysis using RNA sequencing and bioinformatic analyses.
Main Results:
- HDAC-1, -2, and -3 inhibitors (RGFP963, RGFP968) strongly promoted synaptogenesis.
- Selective HDAC3 inhibition (RGFP966) had minimal impact on synaptogenesis and memory.
- RGFP963 enhanced hippocampal spine density and rescued memory in an Alzheimer's disease model, unlike RGFP966.
Conclusions:
- The memory-enhancing properties of class I HDAC inhibitors depend on isoform selectivity.
- RGFP963's ability to enhance synaptic efficacy may underlie its procognitive effects.
- Specific pathological brain states might benefit from HDAC inhibitors that improve network function via enhanced synapse efficacy.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
914
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
914
01:25Dose-Response Relationship: Selectivity and Specificity
10.8K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.8K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.9K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.9K
01:20Desensitization and Tachyphylaxis
3.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.5K
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
4.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.3K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
3.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
3.0K